Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 15, 2000

View Archived Issues

Oxford Glyco Intends To Raise $215M As It Gains Nasdaq Listing

MediGene Filling Pipeline With U.S.-Based NeuroVir Acquisition

ReNeuron Raises #19.5M In IPO To Fund Stem Cell Technologies

Japan Tobacco Opening London Office To Increase EU Partnering

Wellcome Trust Increasing Spending To #600M Per Year

Lion, Celera Strengthen Their Collaboration In Bioinformatics

French Officials Still Not Ready To Adopt EU Biotech Directive

Merged German Firm Cardion Gains Strong Stem Cell Position

Other News To Note

GenOdyssee, UroGhne Enter Deal On Prostate Cancer SNPs

Parliament, Ministers Find Some Consensus On Directive Update

EU Commissioners Express Support For Biotech Direction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...